Name | (1R,4S) Sertraline Hydrochloride |
---|---|
Synonyms |
trans-(1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Hydrochloride
Trans-(1S)(1R)-N-methyl-4-(3,4-diclorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Hydrochloride trans-(1R,4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride (1R,4S)-sertraline hydrochloride (1R-trans)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1--naphthalenamine Hydrochloride (1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-Methyl-1-naphthalenaMine (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine hydrochloride |
Boiling Point | 443.8ºC at 760 mmHg |
---|---|
Melting Point | 260-262ºC |
Molecular Formula | C17H18Cl3N |
Molecular Weight | 342.69100 |
Flash Point | 222.2ºC |
Exact Mass | 341.05000 |
PSA | 12.03000 |
LogP | 6.37250 |
~% 79896-32-5 |
Literature: Pfizer Inc. Patent: US4556676 A1, 1985 ; US 4556676 A |
Precursor 1 | |
---|---|
DownStream 0 |